Israel Chemicals (NYSE:ICL) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Wednesday.

According to Zacks, “Israel Chemicals Ltd. is a manufacturer of specialty fertilizers and specialty phosphates, flame retardants and water treatment solutions. It operates primarily in three markets: agriculture, food and engineered materials. The Company’s products include bromine specialty chemicals, potash, phosphate fertilizers, and specialty performance and industrial products. It markets its products primarily in Israel, Europe, and the Americas. Israel Chemicals Ltd. is headquartered in Tel Aviv, Israel. “

Separately, ValuEngine raised Israel Chemicals from a “hold” rating to a “buy” rating in a research note on Friday, August 24th. Two equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $5.25.

Shares of Israel Chemicals stock opened at $5.77 on Wednesday. The company has a market cap of $7.31 billion, a P/E ratio of 18.61 and a beta of 1.15. Israel Chemicals has a 12 month low of $3.85 and a 12 month high of $5.90. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.35 and a quick ratio of 0.76.

Israel Chemicals (NYSE:ICL) last posted its quarterly earnings data on Wednesday, August 1st. The basic materials company reported $0.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.08 by $0.01. The business had revenue of $1.37 billion during the quarter. Israel Chemicals had a return on equity of 14.16% and a net margin of 22.74%. Israel Chemicals’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same period in the previous year, the business earned $0.05 earnings per share. research analysts predict that Israel Chemicals will post 0.36 earnings per share for the current year.

Several large investors have recently bought and sold shares of ICL. Delek Group Ltd. lifted its stake in shares of Israel Chemicals by 21.9% in the 1st quarter. Delek Group Ltd. now owns 4,878,285 shares of the basic materials company’s stock valued at $20,596,000 after purchasing an additional 876,965 shares during the last quarter. Hsbc Holdings PLC raised its holdings in shares of Israel Chemicals by 1,776.5% in the first quarter. Hsbc Holdings PLC now owns 856,705 shares of the basic materials company’s stock worth $3,632,000 after buying an additional 811,050 shares during the period. Clal Insurance Enterprises Holdings Ltd raised its holdings in shares of Israel Chemicals by 2,050.6% in the second quarter. Clal Insurance Enterprises Holdings Ltd now owns 649,982 shares of the basic materials company’s stock worth $2,990,000 after buying an additional 619,759 shares during the period. Swiss National Bank raised its holdings in shares of Israel Chemicals by 31.3% in the first quarter. Swiss National Bank now owns 2,581,953 shares of the basic materials company’s stock worth $10,912,000 after buying an additional 615,582 shares during the period. Finally, Van ECK Associates Corp raised its holdings in shares of Israel Chemicals by 40.4% in the second quarter. Van ECK Associates Corp now owns 2,014,048 shares of the basic materials company’s stock worth $9,265,000 after buying an additional 579,976 shares during the period. 8.11% of the stock is owned by institutional investors and hedge funds.

Israel Chemicals Company Profile

Israel Chemicals Ltd. operates as a specialty minerals company worldwide. The company operates through two segments, Essential Minerals and Specialty Solutions. The company extracts potash from the Dead Sea; mines and produces potash, salt, and Polysulphate; and produces, markets, and sells pure magnesium and magnesium alloys, as well as produces dry carnallite and related by-products, including chlorine and sylvinite.

Featured Story: How is an ETF different from a mutual fund?

Get a free copy of the Zacks research report on Israel Chemicals (ICL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Israel Chemicals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Israel Chemicals and related companies with MarketBeat.com's FREE daily email newsletter.